SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-24-000158
Filing Date
2024-01-25
Accepted
2024-01-25 16:06:45
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g083979_sch13ga.htm SC 13G/A 29195
  Complete submission text file 0001753926-24-000158.txt   30689
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Subject) CIK: 0001347242 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93847 | Film No.: 24562203
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LIPELLA PHARMACEUTICALS INC. 7800 SUSQUEHANNA ST., SUITE 505 PITTSBURGH PA 15208
Business Address
Huang Leaf (Filed by) CIK: 0001959358 (see all company filings)

Type: SC 13G/A